# Irbesartan and Amlodipine Combination in Controlling Blood Pressure

> **NCT00950066** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 270 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** IRBESARTAN (SR47436)
- **DRUG:** Amlodipine
- **DRUG:** Irbesartan / Amlodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00950066
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2011-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950066, "Irbesartan and Amlodipine Combination in Controlling Blood Pressure". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00950066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*